IMARA Inc. (IMRA) financial statements (2022 and earlier)

Company profile

Business Address 116 HUNTINGTON AVENUE
BOSTON, MA 02116
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:90,30088,200
Cash and cash equivalents48,30947,698
Short-term investments41,96940,524
Other undisclosed cash, cash equivalents, and short-term investments22(22)
Other undisclosed current assets2,3962,205
Total current assets:92,69690,405
Noncurrent Assets
Operating lease, right-of-use asset525 
Property, plant and equipment250349
Other noncurrent assets17588
Total noncurrent assets:950437
TOTAL ASSETS:93,64690,842
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities6,9646,247
Accounts payable2,3601,971
Accrued liabilities4,6044,276
Other undisclosed current liabilities246 
Total current liabilities:7,2106,247
Noncurrent Liabilities
Long-term debt and lease obligation406 
Operating lease, liability406 
Liabilities, other than long-term debt 160
Deferred rent credit 160
Other undisclosed noncurrent liabilities(406) 
Total noncurrent liabilities:406160
Total liabilities:7,6166,407
Stockholders' equity
Stockholders' equity attributable to parent86,03084,435
Common stock2718
Additional paid in capital233,516180,526
Accumulated other comprehensive income (loss)(16)4
Accumulated deficit(147,497)(96,113)
Total stockholders' equity:86,03084,435
TOTAL LIABILITIES AND EQUITY:93,64690,842

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
Operating expenses(51,442)(41,698)
Operating loss:(51,442)(41,698)
Nonoperating income58338
Other nonoperating expense(175)(145)
Net loss attributable to parent:(51,384)(41,360)
Preferred stock dividends and other adjustments(7,900)(7,858)
Net loss available to common stockholders, diluted:(59,284)(49,218)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
Net loss:(51,384)(41,360)
Comprehensive loss:(51,384)(41,360)
Other undisclosed comprehensive loss, net of tax, attributable to parent(20)(28)
Comprehensive loss, net of tax, attributable to parent:(51,404)(41,388)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: